Clinical Research Detail Title Of Study A clinical trial to study the effects of bevacizumab plus capecitabine vs. bevacizumab alone as maintenance therapy in patients with HER2-negative metastatic breast cancer that has not progressed during initial docetaxel plus bevacizumab therapy Disease Condition Metastatic breast cancer Phase of Trial Phase-3 & 4 Discipline Oncology Start date of Trial 7/17/2009 Closing Date of Trial 7/17/2014 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]